Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study: The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin

NCT04601077 is registered in ClinicalTrials.gov with Nitric Oxide Innovations LLC as lead sponsor.

NCT NCT04601077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04601077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study: The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African American and Hispanic Origin
Lead sponsor
Nitric Oxide Innovations LLC
Phase
Phase 1/2
Overall status
Terminated
Start date
November 1, 2020
Completion date
November 30, 2022
Enrollment
524 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19